Search details
1.
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination.
Pancreatology
; 20(6): 1115-1122, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32778368
2.
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology
; 20(1): 101-109, 2020 Jan.
Article
in English
| MEDLINE | ID: mdl-31787526
Results
1 -
2
de 2
1
Next >
>>